| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Diamedica Therapeutics Inc. (DMAC) has 7 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. DMAC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.83M | $51.63M | - | |
| 10% | 8.38M | $49.04M | - | |
| 10% | 4.96M | $29.01M | - | |
| Other | 450.0K | $2.63M | - | |
| Dir | 398.6K | $2.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Von Koch Thomas67 | 10% Owner | Buy | 2,855,847 | $1.24 | $3,526,971.05 | New | +22.3% | +75.0% | |
| Dec 1, 2022 | Giuffre Randall Michael84 | Director | Buy | 819 | $1.19 | $974.61 | +0.5% | +47.5% | +115.8% | |
| Dec 1, 2022 | Giuffre Randall Michael84 | Director | Buy | 67,228 | $1.20 | $80,462.65 | +18.2% | +47.5% | +115.8% | |
| Nov 16, 2022 | Pauls Dietrich John49 | President And CEO | Buy | 20,000 | $1.21 | $24,200.00 | +55.9% | +20.7% | +96.7% | |
| Jul 8, 2022 | Von Koch Thomas67 | 10% Owner | Buy | 207,974 | $1.33 | $275,898.31 | +7.9% | -1.5% | +191.1% | |
| Sep 15, 2021 | Alcorn Harry W Jr | SVP, Clinical Operations | Buy | 15,000 | $3.80 | $56,959.50 | +52.5% | -2.8% | -62.5% | |
| Aug 16, 2021 | Burroughs Amy L.57 | Director | Buy | 44,950 | $3.15 | $141,592.50 | New | +22.5% | -44.1% | |
| Aug 16, 2021 | Pilnik Richard D.47 | Director | Buy | 15,000 | $3.27 | $49,064.00 | +9.2% | +22.5% | -44.1% | |
| Aug 16, 2021 | Alcorn Harry W Jr | Senior VP, Clinical Operations | Buy | 20,721 | $3.09 | $64,053.86 | +56.7% | +22.5% | -44.1% | |
| Aug 16, 2021 | Pauls Dietrich John49 | President And CEO | Buy | 5,000 | $3.14 | $15,700.00 | +16.2% | +22.5% | -44.1% |